(S)-2-((tert-Butoxycarbonyl)amino)-3-(quinolin-2-yl)propanoic acid, 95.0%, 1g

O-[(Ethoxycarbonyl)cyanomethylenamino]-N,N,N',N'-tetramethyluronium Tetrafluoroborate>98.0%(HPLC)(N)5g

1-Pyrrolidinamine>98.0%(T)1g

GC capillary column ROTI®Cap-FFAP, 25 m, 0.32 mm, 0.25 µm, 1 Piece(s)

1-(Thiazol-2-yl)piperidin-4-amine hydrochloride, 95+%, 1g

3-Mesitylpropan-1-ol, 95%, 5g

tert-Butyl (3S,4S)-3-amino-4-fluoropiperidine-1-carboxylate, 97%, 500mg

2-(pyrrolidin-3-yloxy)thiazole hydrochloride, 95.0%, 250mg

3-TRIFLUOROMETHYL-PYRROLIDINE-1,3-DICARBOXYLIC ACID 1-TERT-BUTYL ESTER, 95.0%, 250mg

Xphos, min. 97%, 5 g, glass packaging

1-[(1R,2S,4R)Bicyclo[2.2.1]hept-5-en-2-yl] methaneamine oxalate, 95.0%, 250mg

5-Methyl-4-phenyl-2-(2-pyridyl)thiazole, 1g

2-Phenylpropan-2-yl Benzodithioate>98.0%(HPLC)1g